loanDepot (LDI) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates


Analysts on Wall Street project that The Cooper Companies (COO) will announce quarterly earnings of $3.47 per share in its forthcoming report, representing an increase of 26.2% year over year. Revenues are projected to reach $919.68 million, increasing 8.4% from the same quarter last year.

Over the last 30 days, there has been a downward revision of 0.7% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts’ collective reconsideration of their initial forecasts over the course of this timeframe.

Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.

While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts’ projections for specific key metrics can offer valuable insights.

Bearing this in mind, let’s now explore the average estimates of specific The Cooper Companies metrics that are commonly monitored and projected by Wall Street analysts.

Analysts forecast ‘Revenue by Category- CSI’ to reach $302.77 million. The estimate points to a change of +5.8% from the year-ago quarter.

The consensus estimate for ‘Revenue by Category- CVI’ stands at $616.43 million. The estimate indicates a year-over-year change of +9.7%.

Analysts expect ‘Revenue by Category- CSI- Fertility’ to come in at $117.36 million. The estimate points to a change of +8.2% from the year-ago quarter.

Analysts predict that the ‘Revenue by Category- CSI- Office and surgical’ will reach $185.30 million. The estimate points to a change of +4.2% from the year-ago quarter.

Analysts’ assessment points toward ‘Revenue by Category- CVI- Multifocal’ reaching $75.12 million. The estimate suggests a change of +16.3% year over year.

The average prediction of analysts places ‘Revenue by Category- CVI- Toric’ at $207.28 million. The estimate indicates a year-over-year change of +12.8%.

The combined assessment of analysts suggests that ‘Revenue by Category- CVI- Non single-use sphere, other’ will likely reach $146.61 million. The estimate indicates a year-over-year change of +2%.

According to the collective judgment of analysts, ‘Revenue by Category- CVI- Single-use sphere’ should come in at $187.86 million. The estimate indicates a year-over-year change of +10.7%.

View all Key Company Metrics for The Cooper Companies here>>>

Over the past month, The Cooper Companies shares have recorded returns of +1.9% versus the Zacks S&P 500 composite’s +8.6% change. Based on its Zacks Rank #3 (Hold), COO will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today’s Zacks Rank #1 (Strong Buy) stocks here >>>>

Zacks Names “Single Best Pick to Double”

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s credited with a “watershed medical breakthrough” and is developing a bustling pipeline of other projects that could make a world of difference for patients suffering from diseases involving the liver, lungs, and blood. This is a timely investment that you can catch while it emerges from its bear market lows.

It could rival or surpass other recent Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

The Cooper Companies, Inc. (COO) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.



Image and article originally from www.nasdaq.com. Read the original article here.

By Zacks